|
1
|
Gavrilovic IT and Posner JB: Brain
metastases: Epidemiology and pathophysiology. J Neurooncol.
75:5–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
German Society for Neurology: Brain
metastases and meningeosis neoplastica. Leitlinien für Diagnostik
und Therapie in der Neurologie: Registry Number 030/060. 2011.(In
German).
|
|
3
|
DiStefano A, Yap Yong Y, Hortobagyi GN and
Blumenschein GR: The natural history of breast cancer patients with
brain metastases. Cancer. 44:1913–1918. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho SY and Choi HY: Causes of death and
metastatic patterns in patients with mammary cancer. Ten-year
autopsy study. Am J Clin Pathol. 73:232–234. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee YT: Breast carcinoma: Pattern of
metastasis at autopsy. J Surg Oncol. 23:175–180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsukada Y, Fouad A, Pickren JW and Lane
WW: Central nervous system metastasis from breast carcinoma.
Autopsy study. Cancer. 52:2349–2354. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evans AJ, James JJ, Cornford EJ, Chan SY,
Burrell HC, Pinder SE, Gutteridge E, Robertson JF, Hornbuckle J and
Cheung KL: Brain metastases from breast cancer: Identification of a
high-risk group. Clin Oncol (R Coll Radiol). 16:345–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeichner SB, Cavalcante L, Suciu GP, Ruiz
AL, Hirzel A and Krill-Jackson E: Long-term survival of women with
locally advanced breast cancer with ≥10 involved lymph nodes at
diagnosis. Asian Pac J Cancer Prev. 15:3435–3441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pestalozzi BC, Zahrieh D, Price KN,
Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E,
Pagani O, et al: Identifying breast cancer patients at risk for
central nervous system (CNS) metastases in trials of the
international breast cancer study group (IBCSG). Ann Oncol.
17:935–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gabos Z, Sinha R, Hanson J, Chauhan N,
Hugh J, Mackey JR and Abdulkarim B: Prognostic significance of
human epidermal growth factor receptor positivity for the
development of brain metastasis after newly diagnosed breast
cancer. J Clin Oncol. 24:5658–5663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kreienberg R, Albert US, Follmann M, Kopp
IB, Kühn T and Wöckel A: Interdisciplinary GoR level III Guidelines
for the Diagnosis, Therapy and Follow up Care of Breast Cancer:
Short version AWMF Registry No.: 032 045OL AWMF Register Nummer:
032 045OL Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd.
73:556–583. 2013.PubMed/NCBI
|
|
12
|
Karam I, Nichol A, Woods R and Tyldesley
S: Population-based outcomes after whole brain radiotherapy and
re-irradiation in patients with metastatic breast cancer in the
trastuzumab era. Radiat Oncol. 6:1812011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ogawa K, Yoshii Y, Nishimaki T, Tamaki N,
Miyaguni T, Tsuchida Y, Kamada Y, Toita T, Kakinohana Y, Tamaki W,
et al: Treatment and prognosis of brain metastases from breast
cancer. J Neurooncol. 86:231–238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dawood S, Gonzalez-Angulo AM, Albarracin
C, Yu TK, Hortobagyi GN, Buchholz TA and Woodward WA: Prognostic
factors of survival in the trastuzumab era among women with breast
cancer and brain metastases who receive whole brain radiotherapy: A
single-institution review. Cancer. 116:3084–3092. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Le Scodan R, Jouanneau L, Massard C,
Gutierrez M, Kirova Y, Cherel P, Gachet J, Labib A and
Mouret-Fourme E: Brain metastases from breast cancer: Prognostic
significance of HER-2 overexpression, effect of trastuzumab and
cause of death. BMC Cancer. 11:3952011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kocher M, Soffietti R, Abacioglu U, Villà
S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD,
Carrie C, et al: Adjuvant whole-brain radiotherapy versus
observation after radiosurgery or surgical resection of one to
three cerebral metastases: Results of the EORTC 22952–26001 study.
J Clin Oncol. 29:134–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nam BH, Kim SY, Han HS, Kwon Y, Lee KS,
Kim TH and Ro J: Breast cancer subtypes and survival in patients
with brain metastases. Breast Cancer Res. 10:R202008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anders CK, Deal AM, Miller CR, Khorram C,
Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM and
Carey LA: The prognostic contribution of clinical breast cancer
subtype, age, and race among patients with breast cancer brain
metastases. Cancer. 117:1602–1611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sperduto PW, Kased N, Roberge D, Chao ST,
Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, et al: The
effect of tumor subtype on the time from primary diagnosis to
development of brain metastases and survival in patients with
breast cancer. J Neurooncol. 112:467–472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin NU and Winer EP: Brain metastases: The
HER2 paradigm. Clin Cancer Res. 13:1648–1655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gabos Z, Sinha R, Hanson J, Chauhan N,
Hugh J, Mackey JR and Abdulkarim B: Prognostic significance of
human epidermal growth factor receptor positivity for the
development of brain metastasis after newly diagnosed breast
cancer. J Clin Oncol. 24:5658–5663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Church DN, Modgil R, Guglani S, Bahl A,
Hopkins K, Braybrooke JP, Blair P and Price CG: Extended survival
in women with brain metastases from HER2 overexpressing breast
cancer. Am J Clin Oncol. 31:250–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu MT, Hsieh CY, Wang AY, Chang TH, Pi
CP, Huang CC, Huang CY and Liou CH: Prognostic factors affecting
the outcome of brain metastases from breast cancer. Support Care
Cancer. 14:936–942. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patchell RA, Tibbs PA, Walsh JW, Dempsey
RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS and Young
B: A randomized trial of surgery in the treatment of single
metastases to the brain. N Engl J Med. 322:494–500. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rades D, Kieckebusch S, Haatanen T,
Lohynska R, Dunst J and Schild SE: Surgical resection followed by
whole brain radiotherapy versus whole brain radiotherapy alone for
single brain metastasis. Int J Radiat Oncol Biol Phys.
70:1319–1324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Neill BP, Iturria NJ, Link MJ, Pollock
BE, Ballman KV and O'Fallon JR: A comparison of surgical resection
and stereotactic radiosurgery in the treatment of solitary brain
metastases. Int J Radiat Oncol Biol Phys. 55:1169–1176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Murray KJ, Scott C, Greenberg HM, Emami B,
Seider M, Vora NL, Olson C, Whitton A, Movsas B and Curran W: A
randomized phase III study of accelerated hyperfractionation versus
standard in patients with unresected brain metastases: A report of
the radiation therapy oncology group (RTOG) 9104. Int J Radiat
Oncol Biol Phys. 39:571–574. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rades D, Haatanen T, Schild SE and Dunst
J: Dose escalation beyond 30 grays in 10 fractions for patients
with multiple brain metastases. Cancer. 110:1345–1350. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davey P, Hoegler D, Ennis M and Smith J: A
phase III study of accelerated versus conventional hypofractionated
whole brain irradiation in patients of good performance status with
brain metastases not suitable for surgical excision. Radiother
Oncol. 88:173–176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mahmoud-Ahmed AS, Suh JH, Lee SY,
Crownover RL and Barnett GH: Results of whole brain radiotherapy in
patients with brain metastases from breast cancer: A retrospective
study. Int J Radiat Oncol Biol Phys. 54:810–817. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meyer A, Steinmann D, Malaimare L,
Karstens JH and Bremer M: Prediction of prognosis regarding
fractionation schedule and survival in patients with whole-brain
radiotherapy for metastatic disease. Anticancer Res. 28:3965–3969.
2008.PubMed/NCBI
|
|
32
|
Hsu F, Kouhestani P, Nguyen S, Cheung A,
McKenzie M, Ma R, Toyota B and Nichol A: Population-based outcomes
of boost versus salvage radiosurgery for brain metastases after
whole brain radiotherapy. Radiother Oncol. 108:128–131. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kondziolka D, Patel A, Lunsford LD, Kassam
A and Flickinger JC: Stereotactic radiosurgery plus whole brain
radiotherapy versus radiotherapy alone for patients with multiple
brain metastases. Int J Radiat Oncol Biol Phys. 45:427–434. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Andrews DW, Scott CB, Sperduto PW,
Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J,
Bahary JP, et al: Whole brain radiation therapy with or without
stereotactic radiosurgery boost for patients with one to three
brain metastases: Phase III results of the RTOG 9508 randomised
trial. Lancet. 363:1665–1672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Assouline A, Levy A, Chargari C,
Lamproglou I, Mazeron JJ and Krzisch C: Whole brain radiotherapy:
Prognostic factors and results of a radiation boost delivered
through a conventional linear accelerator. Radiother Oncol.
99:214–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aoyama H, Shirato H, Tago M, Nakagawa K,
Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, et al:
Stereotactic radiosurgery plus whole-brain radiation therapy vs
stereotactic radiosurgery alone for treatment of brain metastases:
A randomized controlled trial. JAMA. 295:2483–2491. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang EL, Wefel JS, Hess KR, Allen PK,
Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH and
Meyers CA: Neurocognition in patients with brain metastases treated
with radiosurgery or radiosurgery plus whole-brain irradiation: A
randomised controlled trial. Lancet Oncol. 10:1037–1044. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamamoto M, Serizawa T, Shuto T, Akabane
A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, et
al: Stereotactic radiosurgery for patients with multiple brain
metastases (JLGK0901): A multi-institutional prospective
observational study. Lancet Oncol. 15:387–395. 2014. View Article : Google Scholar : PubMed/NCBI
|
